Research Snapshot: Researchers Identify Genes That Predict Pediatric AML Outcomes
UF researchers identified genes that were associated with resistance or sensitivity to chemotherapy and linked these with patients’ treatment outcomes.
UF News
The Supercomputer Transforming the University of Florida Into an AI Hub
UF has invested $24 million to upgrade its HiPerGator supercomputer, positioning Gainesville as a leading AI research hub with one of the world's fastest machines, supported by NVIDIA's cutting-edge technology.
Gryphon Bio, Inc. Pioneers Novel Blood Biomarker Panel To Monitor Treatment Journey for Patients With Traumatic Brain Injury and Alzheimer’s
UF Innovate's funding institution Gryphon Bio, Inc. is pursuing observational clinical studies with U.S. and international partners to validate a novel blood biomarker panel for early detection and monitoring of TBI and Alzheimer’s disease.
Caidya: Clinical Research Organization Raises $165 Million
Caidya, formed through the merger of dMed and UF startup Clinipace, announced the closing of a $165 million strategic growth investment from funds managed by Rubicon Founders, a U.S.-based healthcare investment firm focused on building transformational companies.
Interview With Dr. Rob Ferl & Dr. Anna-Lisa Paul of Astraeus Space Institute
UF space researchers Dr. Rob Ferl and Dr. Anna-Lisa Paul share insights and discuss key discoveries from their research on the potential for life in space.
Targeting Protein Restores Aging Blood Cells, UF Researchers Find
UF researchers have discovered a way to prevent chronic inflammation that harms blood stem cells in the bone marrow, weakens the immune system, and reduces chemotherapy effectiveness.
NASA’s Kennedy Space Center and Florida Universities Unite To Propel Space Exploration
The University of Florida is partnering with NASA’s Kennedy Space Center through the Florida University Space Research Consortium to advance space exploration and strengthen Florida’s leadership in the global aerospace industry.
Researchers Explore Breakthrough Approach To Combat Devastating Citrus Greening Disease
UF researchers are testing a new citrus tree that fights the insects causing citrus greening, offering hope for Florida's struggling citrus industry.
Genascence Announces Six-Month Results From Phase 1b DONATELLO Trial Indicating GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms
UF startup Genascence Corporation, a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, announced positive interim safety and biomarker results from the Phase 1b DONATELLO clinical trial evaluating GNSC-001.
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology
UF startup Cannabix Technologies Inc., developer of marijuana and alcohol breath testing devices, has announced that it has made significant updates to its Cannabix Marijuana Breathalyzer technology to meet suggested emerging regulatory requirements in preparation for marketing.
Want our news in your inbox every Monday morning? You can!